Instrumental Insemination 1982
DOI: 10.1007/978-94-009-7467-8_9
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of Motility in Fresh and Cryo-Preserved Semen by Kallikrein and Caffeine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
3
0

Year Published

1985
1985
2009
2009

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 1 publication
1
3
0
Order By: Relevance
“…However, this reduction was maintained at the same level achieved with ECM. This result was to be expected, based on experience with a similar cryoprotectant [12] and the value of kallikrein in the enhancement of motility in cryopreserved semen [6]. The trend of near equality of both cryoprotectants, ECM and ICP.…”
Section: Discussionsupporting
confidence: 66%
“…However, this reduction was maintained at the same level achieved with ECM. This result was to be expected, based on experience with a similar cryoprotectant [12] and the value of kallikrein in the enhancement of motility in cryopreserved semen [6]. The trend of near equality of both cryoprotectants, ECM and ICP.…”
Section: Discussionsupporting
confidence: 66%
“…This fact has been documented for rats (Wyker and Howards -1977), for guinea pigs (Frenkel et al -1973), for bulls (Hoskins et al -1975), and for men (Mooney et al, -1972). A motility-enhancing effect is ascribed to both kallikrein and caffeine, even though the results differ as to the degree and duration of the stimulation (Bratanov et al -1978;Kaden and Grossgebauer -1980;Schill -1975;Schoenfeld -1975).…”
Section: Discussionmentioning
confidence: 89%
“…A stimulation of "spermatocele spermatozoa" by caffeine should be discussed in connection with artificial insemination, as was also mentioned by Johnson et al (1974). In addition to caffeine, the most often recommended stimulants for homologous insemination are seminal plasma (Lindholmer -1974) and kallikrein (Bratanov et al -1978;Kaden and Grossgebauer -1980;Schill -1978). To date, however, there is no proof that the "fertility" of spermatozoa is increased by such improvements in spermatozoa motility.…”
Section: Discussionmentioning
confidence: 99%
“…In the last decades, a number of drugs have been presented in the literature as having a significant positive effect on sperm motility both in vitro and in vivo. Much research has been done with kallikrein [15,18,211, proving a significant effect of this compound on sperm motility in vitro [6][7][8]161 as well as a clinical benefit [4, 11, 14, 17, 20, 221, yet only few randomized studies have been performed to compare the systemic drug effect in vivo [lo, 161. Most of these publications came from Europe and some from Japan, with criticism mainly issuing from the United States. Nevertheless, a more effective drug to improve sperm motility is currently not available.…”
mentioning
confidence: 99%